Episoder
-
Lee Hartner MD discusses what factors community physicians should take into account when deciding which lumps and bumps to biopsy. He highlights some of the challenges that physicians and patients experience when certain lumps and bumps have been biopsied or removed before these patients are seen by the team and he shares how the expertise of Penn Medicine pathologists contributes to the best outcomes for sarcoma patients.
-
Peter Abt MD and Kim Olthoff MD discuss responsible expansion of liver transplantation. They offer the benefits of the Penn Liver Transplantation program and what they see as the single greatest challenge facing the field of liver transplantation today. Additionally, they share how Penn is finding innovative ways to increase access to deceased donor liver transplantation and the recommendations for timing of referral in liver transplantation
-
Manglende episoder?
-
Bobby Ndu MD, MBA highlights minimally invasive foot and ankle surgery. He shares how minimally invasive surgery differs from traditional foot and ankle surgery, the benefits of these procedures and what makes Penn Orthopaedics unique when it comes to minimally invasive foot and ankle surgery.
-
Bill Jaffe MD and Jennifer Lloyd-Harris MD, MPH discuss aquablation and BPH treatment. They share how many of the existing treatments for BPH involve a tradeoff between efficacy and complications, who it is indicated for and what procedural or operative advantages Aquablation brings to BPH therapy. Additionally, they offer how this new treatment complements the total approach to BPH at Penn Urology.
-
While pregnancy is safe to undertake, there are specific risks for women with MS trying to conceive. Rachel Brandstadter, MD discusses these concerns and how can they be addressed for women with MS.
Additionally, she explains the services Penn Medicine offers along the way, strategies for management of MS in the postpartum period and what referring providers should be aware of before they refer a patient to the MS and women’s health specialists at Penn Medicine. -
While the incidence of heart failure with reduced ejection fraction (HFrEF) has decreased, the incidence of heart failure with preserved ejection fraction (HFpEF) continues to rise.
Stuart Prenner MD explains the role of ejection fraction in heart failure diagnostics and the clinical indicators referring providers should be aware of when considering HFpEF. He explores the diagnostic strategies the team at Penn Medicine employ and the specific interventions recently approved, including SGLT2 inhibitors. Lastly, he shares how the HFpEF program at Penn Medicine has the ability to care for these patients with a multidisciplinary team. -
Ty Dunn MD, MS discusses simultaneous pancreas-kidney (SPK) transplant. She emphasizes the relationship between type 1 diabetes and the destruction of these organs as well as the indications for both pancreas transplantation alone and SPK transplant. She shares the differences in the outcomes for SPK transplant versus pancreas-alone, or pancreas after kidney transplant and she tells us about the new allocation policies for kidney and pancreas transplantation. Lastly, she offers the recommendations for timing of referral for SPK transplant evaluation, and the advantages for individuals considering Penn Medicine’s Kidney and Pancreas Transplant program.
-
Donald O'Rourke, MD, discusses the microenvironment of glioblastomas, Penn's upcoming clinical trial for recurrent glioblastoma multiforme (GBM) and his outlook on the future research for GBM.
-
Nicole Saur, MD, discusses the launch of the PeRioperative Evaluation and Planning (PREP) Program at Penn Medicine and the PREP Program's multidisciplinary, multiphase approach for optimization of older patients undergoing colorectal surgery.
-
Cara A. Cipriano, MD, MSc, Chief of Orthopaedic Oncology and Associate Professor of Orthopaedic Surgery, discusses her role at Penn Medicine and her commitment to diversify the field of orthopaedics.
-
Roger Cohen, MD, and Donald Siegel, MD, PhD, discuss the enrolling novel CAR T-Cell medullary thyroid cancer clinical trial at Penn Medicine, and which patients should participate in the clinical trial.
-
In this engaging interview, Rhondalyn McLean, MD, reviews the evolution of heart transplantation in the U.S. and at Penn Medicine, including indications, the importance of early referral, and long-term survival. She also examines recent transplant allocation changes and how Penn Medicine is working to expand the donor pool, including transplanting hearts from individuals with hepatitis C.
-
Chris Anthony, MD shares how hip labral tears are being addressed by the Penn Hip Preservation program and the importance of early referral for hip preservation evaluation and treatment.
- Vis mere
